4-(4Methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)

   
   

The present invention relates to a new compound of formula I as a free base or a pharmaceutically acceptable salt thereof, a process for the preparation, pharmaceutical formulations containing said therapeutically active compound and to the use of said compound in therapy. 1

La presente invenzione riguarda un nuovo residuo della formula I come base libera o un sale farmaceuticamente accettabile di ciĆ², un procedimento per la preparazione, formulazioni farmaceutiche che contengono compound attivo dal punto di vista terapeutico detto ed all'uso del residuo detto nella terapia. 1

 
Web www.patentalert.com

< Activator of peroxisome proliferator-activated receptor

< Treating neurological disorders using selective antagonists of persistent sodium current

> Phenyl naphthol ligands for thyroid hormone receptor

> 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical

~ 00165